Lung Cancer

Lung Cancer Webinars

Bringing experiences together

Welcome to the Siemens Healthineers Lung Cancer Webinar series, designed to provide healthcare professionals, researchers, and patients with the latest information and insights on lung cancer screening, diagnosis and treatment. Our webinars feature leading experts in the field of oncology who share their perspectives on the latest advancements in lung cancer. 


Dive into the forefront of lung cancer management at our symposium “Interdisciplinary perspectives in lung cancer: advancements in screening modalities and surgical implications“.

  • Sebastian Schmidt, Senior Manager for Medical Affairs at Siemens Healthineers Forchheim
    “ Update on lung screening in Europe”
  • Ante Marušić, MD, PhD, LCS Team, Zagreb, Croatia
    “Three years after the first lung screening: experience sharing from Croatia”
  • Rozemarijn Vliegenthart, MD, PhD, Professor of Radiology at the University of Groningen, the Netherlands
    “Lung screening: current challenges and solutions”
  • Felix Herth, MD, PhD, Professor of Internal Medicine and Pulmonology at the University of Heidelberg, Germany
    “The role of pulmonology in lung cancer screening”
  • To understand the status of lung cancer screening programs in the EU
  • To learn which steps are to be considered in setting up a lung screening program
  • To understand the learnings in setting up a lung screening program
  • To learn how AI can be used in lung screening
  • To understand the role of pulmonology in the lung cancer screening process
  • Dr. Sebastian Schmidt, Head of CT Strategy, Innovation & Medical Affairs at Siemens Healthineers, Germany
  • Prof. Marie Pierre Revel, Head of Radiology department at Cochin hospital, France
  • Prof. Dr. med. Hans-Ulrich Kauczor, Head of clinic for diagnostic and interventional radiology at Heidelberg University Hospital, Germany
  • Mélisande Rouger, ESR moderator
  • To understand the main benefit of AI in lung cancer screening
  • To evaluate the importance of lung screening and the role of radiologists in driving its implementation
  • To analyze the potential and challenges of using AI in lung cancer screening
  • To understand how AI can improve lung cancer screening by analyzing medical imaging data
  • To identify non-oncological factors that should be considered when performing lung cancer screening
  • General considerations: Steps towards the implementation of lung cancer screening programs at European level (Dr. Sebastian Schmidt, Head of CT Strategy, Innovation & Medical Affairs at Siemens Healthineers)
  • Lung cancer screening in the UK: Experiences and insights in a trailer-based program (Professor Richard Booton2 PhD FRCP, Consultant Respiratory Physician, Honorary MAHSC Clinical Professor & Clinical Director, Directorate of Lung Cancer & Thoracic Surgery, North West Lung Centre, Wythenshawe Hospital, Manchester, UK)
  • Lung cancer screening in Poland: Organizational program set-up (Joanna Bidzińska2, Ph.D., EMBA, Project coordinator of National Lung Cancer Screening in the University Clinical Centre in Gdańsk for the northern Macroregion of Poland)
  • Q&A
  • Why is lung cancer screening a critical factor in reducing lung cancer mortality?
  • What is the status of lung cancer screening programs in the EU?
  • How can a screening program be implemented?
  • What are possible approaches on how to set up a lung cancer screening program?
  • What are the lessons or pitfalls?
  • Experience with the implementation of LCS in Poland: How Poland set up their lung cancer screening program, Radiologist and lung cancer screening. Polish experience (Prof. Witold Rzyman2, Gdansk / Poland)
  • CT Technologies for Lung Cancer Screening: Which technology parameters are important to achieve good quality images at ultra low dose, what needs to be considered in finding your local LCS protocol (Prof. Dr. Marc Kachelrieß2, Heidelberg / Germany)
  • The role of Artificial Intelligence (AI) in a LCS Program: Identifying smoking-related disease on LCS CT scans, the role of AI in LCS (Prof. Philippe Grenier2, Suresnes, France)
  • Q&A